Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma
SourceEuropean Journal of Cancer, 116, (2019), pp. 148-157
Article / Letter to editor
Display more detailsDisplay less details
European Journal of Cancer
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.